Provided by Tiger Trade Technology Pte. Ltd.

Bio-Rad Laboratories

380.03
+3.570.95%
Post-market: 380.030.00000.00%19:30 EDT
Volume:341.18K
Turnover:129.81M
Market Cap:10.17B
PE:46.02
High:385.92
Open:385.80
Low:373.47
Close:376.46
52wk High:385.92
52wk Low:236.73
Shares:26.76M
Float Shares:20.89M
Volume Ratio:1.43
T/O Rate:1.63%
Dividend:- -
Dividend Rate:- -
EPS(TTM):8.26
EPS(LYR):27.85
ROE:3.11%
ROA:1.66%
PB:1.42
PE(LYR):13.65

Loading ...

KALA BIO Announces Brief Delay in Quarterly Filing

TIPRANKS
·
Aug 15

BIO-key’s Bottom Line Improves 51% on 13% Rise in Q2 Revenues Reflecting Strength with Government, Defense, and Financial Sector Customers Globally; Call Tomorrow at 10am ET

GlobeNewswire
·
Aug 14

BIO GREEN MED SOLUTION REPORTS SECOND QUARTER FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE

GlobeNewswire
·
Aug 13

BIO-key International Enters into $2.5 Million Warrant Inducement Transaction

GlobeNewswire
·
Aug 11

Imdx Reports Second Quarter 2026 Results and Timely Progress on FDA Review of Graftassuredx

THOMSON REUTERS
·
Aug 11

BIO-key, Visualforma awarded new contract by Portuguese national security agency

TIPRANKS
·
Aug 10

RBC Adjusts PT on Bio-Rad Laboratories to $390 From $370, Maintains Outperform Rating

MT Newswires Live
·
Aug 07

Advanced Authentication Solutions Provider BIO-key Hosts Q2 Investor Call Friday, August 14th at 10am ET

GlobeNewswire
·
Aug 07

SAB BIO Q2 2026 Results: Clinical Spending Widens Net Loss

TradingKey
·
Aug 06

Press Release: SAB BIO Reports Q2 2026 Financial Results and Provides Business Highlights

Dow Jones
·
Aug 06

Bio-Rad Laboratories is Maintained at Neutral by Citigroup

Dow Jones
·
Aug 06

RBC Adjusts Price Target on Bio-Rad Laboratories to $370 From $320, Maintains Outperform Rating

MT Newswires Live
·
Aug 05

Bio-Rad Laboratories, Inc. Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Aug 05

Bio-Rad Laboratories to Cut Jobs, Close Facilities

Dow Jones
·
Aug 05

Bio-Rad Q2 Revenue Beats Analyst Estimates on Clinical Diagnostics Growth

Reuters
·
Aug 05

Bio Rad Laboratories Inc: are Reaffirming Our Full-Year Outlook

THOMSON REUTERS
·
Aug 05

Bio-Rad Laboratories: on July 31, Initiated Restructuring Plan to Improve Operating Performance - SEC Filing

THOMSON REUTERS
·
Aug 05

Bio-Rad Laboratories Q2 Adj. EPS $2.62 Beats $1.75 Estimate, Sales $651.000M Beat $623.989M Estimate

Benzinga Earnings
·
Aug 05

Bio-Rad Q2 Net Income USD 371.4 Million

Reuters
·
Aug 05

Bio-Rad Q2 EPS Usd 13.85

THOMSON REUTERS
·
Aug 05